Specialty Retail
Compare Stocks
5 / 10Stock Comparison
FTEL vs NAUT vs CDNA vs XPOF vs PLNT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Medical - Diagnostics & Research
Leisure
Leisure
FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Retail | Biotechnology | Medical - Diagnostics & Research | Leisure | Leisure |
| Market Cap | $791K | $341M | $1.13B | $209M | $3.66B |
| Revenue (TTM) | $9M | $0.00 | $413M | $299M | $1.38B |
| Net Income (TTM) | $-13M | $-57M | $-8M | $-34M | $229M |
| Gross Margin | 27.0% | — | 48.2% | 83.2% | 54.2% |
| Operating Margin | -114.7% | — | -3.3% | 7.8% | 29.6% |
| Forward P/E | — | — | 23.3x | 9.4x | 14.0x |
| Total Debt | $580K | $30M | $20M | $525M | $443M |
| Cash & Equiv. | $939K | $12M | $65M | $34M | $346M |
FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 23 | Mar 26 | Return |
|---|---|---|---|
| Fitell Corporation (FTEL) | 100 | 2.3 | -97.7% |
| Nautilus Biotechnol… (NAUT) | 100 | 74.9 | -25.1% |
| CareDx, Inc (CDNA) | 100 | 201.5 | +101.5% |
| Xponential Fitness,… (XPOF) | 100 | 19.7 | -80.3% |
| Planet Fitness, Inc. (PLNT) | 100 | 135.1 | +35.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FTEL vs NAUT vs CDNA vs XPOF vs PLNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FTEL is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.19, Low D/E 6.4%, current ratio 4.22x
NAUT ranks third and is worth considering specifically for momentum.
- +275.1% vs FTEL's -78.7%
CDNA is the clearest fit if your priority is growth.
- 13.8% revenue growth vs FTEL's -6.9%
XPOF is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 0 yrs, beta 1.79, yield 2.9%
- Lower P/E (9.4x vs 14.0x)
- 2.9% yield, vs PLNT's 0.0%, (3 stocks pay no dividend)
PLNT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 12.1%, EPS growth 31.0%, 3Y rev CAGR 12.2%
- 215.8% 10Y total return vs CDNA's 393.7%
- Beta 0.41, yield 0.0%, current ratio 2.11x
- 16.5% margin vs FTEL's -141.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.8% revenue growth vs FTEL's -6.9% | |
| Value | Lower P/E (9.4x vs 14.0x) | |
| Quality / Margins | 16.5% margin vs FTEL's -141.4% | |
| Stability / Safety | Beta 0.41 vs XPOF's 1.79 | |
| Dividends | 2.9% yield, vs PLNT's 0.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +275.1% vs FTEL's -78.7% | |
| Efficiency (ROA) | 7.4% ROA vs FTEL's -126.4%, ROIC 35.2% vs -77.3% |
FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PLNT leads in 2 of 6 categories
CDNA leads 1 • FTEL leads 0 • NAUT leads 0 • XPOF leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PLNT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PLNT and NAUT operate at a comparable scale, with $1.4B and $0 in trailing revenue. PLNT is the more profitable business, keeping 16.5% of every revenue dollar as net income compared to FTEL's -141.4%. On growth, CDNA holds the edge at +39.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $9M | $0 | $413M | $299M | $1.4B |
| EBITDAEarnings before interest/tax | -$10M | -$58M | $2M | $35M | $568M |
| Net IncomeAfter-tax profit | -$13M | -$57M | -$8M | -$34M | $229M |
| Free Cash FlowCash after capex | -$13M | -$51M | $65M | -$3M | $267M |
| Gross MarginGross profit ÷ Revenue | +27.0% | — | +48.2% | +83.2% | +54.2% |
| Operating MarginEBIT ÷ Revenue | -114.7% | — | -3.3% | +7.8% | +29.6% |
| Net MarginNet income ÷ Revenue | -141.4% | — | -2.0% | -11.3% | +16.5% |
| FCF MarginFCF ÷ Revenue | -148.4% | — | +15.8% | -1.1% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +24.7% | — | +39.0% | -21.0% | +21.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +67.8% | +7.7% | +126.3% | +79.8% | +30.0% |
Valuation Metrics
Evenly matched — FTEL and XPOF each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, PLNT's 6.8x EV/EBITDA is more attractive than XPOF's 7.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $791,005 | $341M | $1.1B | $209M | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $432,344 | $358M | $1.1B | $700M | $3.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.12x | -5.70x | -54.55x | -3.81x | 17.51x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 23.25x | 9.37x | 14.03x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 7.64x | 6.82x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | — | 2.97x | 0.66x | 2.76x |
| Price / BookPrice ÷ Book value/share | 0.09x | 2.16x | 3.84x | — | — |
| Price / FCFMarket cap ÷ FCF | — | — | 31.21x | 8.45x | 14.36x |
Profitability & Efficiency
PLNT leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
CDNA delivers a -2.6% return on equity — every $100 of shareholder capital generates $-3 in annual profit, vs $-169 for FTEL. FTEL carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to NAUT's 0.19x. On the Piotroski fundamental quality scale (0–9), PLNT scores 9/9 vs NAUT's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -169.3% | -35.0% | -2.6% | — | — |
| ROA (TTM)Return on assets | -126.4% | -29.2% | -1.9% | -9.5% | +7.4% |
| ROICReturn on invested capital | -77.3% | -26.0% | -5.7% | +69.7% | +35.2% |
| ROCEReturn on capital employed | -98.5% | -32.0% | -5.8% | +30.3% | +14.2% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 1 | 5 | 5 | 9 |
| Debt / EquityFinancial leverage | 0.06x | 0.19x | 0.06x | — | — |
| Net DebtTotal debt minus cash | -$358,661 | $18M | -$46M | $491M | $97M |
| Cash & Equiv.Liquid assets | $939,014 | $12M | $65M | $34M | $346M |
| Total DebtShort + long-term debt | $580,353 | $30M | $20M | $525M | $443M |
| Interest CoverageEBIT ÷ Interest expense | -9.50x | — | — | -0.05x | 6.73x |
Total Returns (Dividends Reinvested)
CDNA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PLNT five years ago would be worth $5,865 today (with dividends reinvested), compared to $466 for FTEL. Over the past 12 months, NAUT leads with a +275.1% total return vs FTEL's -78.7%. The 3-year compound annual growth rate (CAGR) favors CDNA at 38.5% vs FTEL's -64.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +62.9% | +40.3% | +14.0% | -30.2% | -58.2% |
| 1-Year ReturnPast 12 months | -78.7% | +275.1% | +41.8% | -35.6% | -52.7% |
| 3-Year ReturnCumulative with dividends | -95.3% | +12.6% | +165.8% | -80.6% | -36.3% |
| 5-Year ReturnCumulative with dividends | -95.3% | -73.4% | -67.3% | -54.3% | -41.4% |
| 10-Year ReturnCumulative with dividends | -95.3% | -74.3% | +393.7% | -54.3% | +215.8% |
| CAGR (3Y)Annualised 3-year return | -64.0% | +4.0% | +38.5% | -42.2% | -14.0% |
Risk & Volatility
Evenly matched — CDNA and PLNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
PLNT is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than XPOF's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CDNA currently trades 93.9% from its 52-week high vs FTEL's 4.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 1.77x | 1.36x | 1.79x | 0.41x |
| 52-Week HighHighest price in past year | $19.20 | $4.31 | $23.24 | $11.14 | $114.47 |
| 52-Week LowLowest price in past year | $0.40 | $0.62 | $10.96 | $3.83 | $37.03 |
| % of 52W HighCurrent price vs 52-week peak | +4.7% | +62.2% | +93.9% | +50.3% | +40.1% |
| RSI (14)Momentum oscillator 0–100 | 30.3 | 50.5 | 59.0 | 46.3 | 14.9 |
| Avg Volume (50D)Average daily shares traded | 122K | 314K | 658K | 632K | 1.9M |
Analyst Outlook
Evenly matched — FTEL and XPOF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NAUT as "Buy", CDNA as "Buy", XPOF as "Buy", PLNT as "Buy". Consensus price targets imply 72.5% upside for PLNT (target: $79) vs -6.7% for NAUT (target: $3). XPOF is the only dividend payer here at 2.92% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $2.50 | $24.00 | $7.00 | $79.15 |
| # AnalystsCovering analysts | — | 5 | 13 | 14 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +2.9% | +0.0% |
| Dividend StreakConsecutive years of raises | 1 | — | — | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $0.16 | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +7.8% | 0.0% | +13.7% |
PLNT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CDNA leads in 1 (Total Returns). 3 tied.
FTEL vs NAUT vs CDNA vs XPOF vs PLNT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FTEL or NAUT or CDNA or XPOF or PLNT a better buy right now?
For growth investors, CareDx, Inc (CDNA) is the stronger pick with 13.
8% revenue growth year-over-year, versus -6. 9% for Fitell Corporation (FTEL). Planet Fitness, Inc. (PLNT) offers the better valuation at 17. 5x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Nautilus Biotechnology, Inc. (NAUT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FTEL or NAUT or CDNA or XPOF or PLNT?
On forward P/E, Xponential Fitness, Inc.
is actually cheaper at 9. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FTEL or NAUT or CDNA or XPOF or PLNT?
Over the past 5 years, Planet Fitness, Inc.
(PLNT) delivered a total return of -41. 4%, compared to -95. 3% for Fitell Corporation (FTEL). Over 10 years, the gap is even starker: CDNA returned +393. 7% versus FTEL's -95. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FTEL or NAUT or CDNA or XPOF or PLNT?
By beta (market sensitivity over 5 years), Planet Fitness, Inc.
(PLNT) is the lower-risk stock at 0. 41β versus Xponential Fitness, Inc. 's 1. 79β — meaning XPOF is approximately 338% more volatile than PLNT relative to the S&P 500. On balance sheet safety, Fitell Corporation (FTEL) carries a lower debt/equity ratio of 6% versus 19% for Nautilus Biotechnology, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FTEL or NAUT or CDNA or XPOF or PLNT?
By revenue growth (latest reported year), CareDx, Inc (CDNA) is pulling ahead at 13.
8% versus -6. 9% for Fitell Corporation (FTEL). On earnings-per-share growth, the picture is similar: Xponential Fitness, Inc. grew EPS 35. 2% year-over-year, compared to -228. 6% for Fitell Corporation. Over a 3-year CAGR, PLNT leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FTEL or NAUT or CDNA or XPOF or PLNT?
Planet Fitness, Inc.
(PLNT) is the more profitable company, earning 16. 5% net margin versus -208. 5% for Fitell Corporation — meaning it keeps 16. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLNT leads at 29. 8% versus -179. 1% for FTEL. At the gross margin level — before operating expenses — PLNT leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FTEL or NAUT or CDNA or XPOF or PLNT more undervalued right now?
On forward earnings alone, Xponential Fitness, Inc.
(XPOF) trades at 9. 4x forward P/E versus 23. 3x for CareDx, Inc — 13. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PLNT: 72. 5% to $79. 15.
08Which pays a better dividend — FTEL or NAUT or CDNA or XPOF or PLNT?
In this comparison, XPOF (2.
9% yield) pays a dividend. FTEL, NAUT, CDNA, PLNT do not pay a meaningful dividend and should not be held primarily for income.
09Is FTEL or NAUT or CDNA or XPOF or PLNT better for a retirement portfolio?
For long-horizon retirement investors, Planet Fitness, Inc.
(PLNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +215. 8% 10Y return). Nautilus Biotechnology, Inc. (NAUT) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PLNT: +215. 8%, NAUT: -74. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FTEL and NAUT and CDNA and XPOF and PLNT?
These companies operate in different sectors (FTEL (Consumer Cyclical) and NAUT (Healthcare) and CDNA (Healthcare) and XPOF (Consumer Cyclical) and PLNT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FTEL is a small-cap quality compounder stock; NAUT is a small-cap quality compounder stock; CDNA is a small-cap quality compounder stock; XPOF is a small-cap quality compounder stock; PLNT is a small-cap deep-value stock. XPOF pays a dividend while FTEL, NAUT, CDNA, PLNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.